Dr. Frank L. Douglas

Massachusettes Institute of Technology, Sloan School of Management

Cambridge, MA

Online Roster Bio

Is establishing at the Sloan School of Management an interdisciplinary center for biomedical innovation. Previously served as chief scientific officer and EVP of Aventis Pharmaceuticals Inc. Previously held management postions at Hoechst Marion Roussell, Marion Merrell Dow and Ciba Geigy. Formerly served as assistant professor of medicine and clinical pharmacology of Hypertenstion Clinic of the Pritzker School of Medicine, University of Chicago.

  • 2005 Second Quarter

Added to: NitroMed Inc. - Lexington, MA

NitroMed is a pharmaceutical company focused on nitric oxide-based drug development. Revenues are $16 million.